Article info
PDFInflammatory bowel disease
Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis
- Correspondence to Dr M Moser, Laboratoire de Physiologie Animale, Université Libre de Bruxelles, Rue des Pr Jeener et Brachet, 12, 6041 Gosselies, Belgium; mmoser{at}ulb.ac.be
Citation
Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis
Publication history
- Revised March 24, 2009
- Accepted April 28, 2009
- First published June 7, 2009.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and British Society of Gastroenterology. All rights reserved.